We attended the Annual Meeting of the European Society for Medical Oncology 2017 (ESMO 2017) from 8th to 12th September in Madrid.
More than 23’000 clinicians and researchers participated in the event providing insights and discussing controversial issues in the field. Cooperation between different disciplines such as oncologists, haematologists clinicians and clinical researchers will be key in the area of immunooncology (IO), where complexity is rapidly increasing.